Dr. Heiferman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1009 S. Wood St., 5th Floor
Chicago, IL 60612Phone+1 312-996-3937Fax+1 312-996-7770
Summary
- Dr. Michael Heiferman is an ophthalmologist in Chicago, IL and is affiliated with University of Illinois Hospital & Health Sciences System. He received his medical degree from Northwestern University and has been in practice 4 years. He specializes in retinal disease and ocular oncology. He has more than 20 publications and over 400 citings.
Education & Training
- University of Illinois College of Medicine at ChicagoFellowship, Surgical Retina and Vitreous, 2019 - 2021
- McGaw Medical Center of Northwestern UniversityResidency, Ophthalmology, 2016 - 2019
- Northwestern University The Feinberg School of MedicineClass of 2015
Certifications & Licensure
- IL State Medical License 2015 - 2026
- CA State Medical License 2021 - 2023
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 41 citationsProgression of subclinical choroidal neovascularization in age-related macular degenerationMichael J. Heiferman, Amani A. Fawzi
Plos One. 2019-06-04 - 136 citationsThree dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2Surabhi Dangi-Garimella, Seth B. Krantz, Morgan R. Barron, Mario A. Shields, Michael J. Heiferman
Cancer Research. 2011-02-01 - 59 citationsConcurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in micePaul J. Grippo, Philip Fitchev, David J. Bentrem, Laleh G. Melstrom, Surabhi Dangi-Garimella
Gut. 2012-10-01
Press Mentions
- First Liver-Directed Therapy for Metastatic Uveal Melanoma Is ApprovedApril 12th, 2024
- Sociodemographic Factors May Be Related to Quality of Ocular Oncology CareJuly 17th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: